Shanghai Explorer

InnoStar, officially known as Shanghai InnoStar Biotech Co., Ltd., is a leading Chinese contract research organization (CRO) specializing in non-clinical pharmaceutical evaluation. Founded in 2003 and headquartered in Shanghai, the company provides a comprehensive suite of services including non-clinical safety evaluation, pharmacokinetics (PK), pharmacodynamics (PD), and bioanalytical services. InnoStar operates as a key subsidiary of the China National Pharmaceutical Group (Sinopharm) and is recognized as the National Shanghai Center for New Drug Safety Evaluation and Research. The company holds multiple international certifications, including GLP compliance from the NMPA, OECD, and FDA, as well as AAALAC accreditation, supporting global drug development programs.